Fundamental Analysis · Last Quarter

FA

A dedicated fundamental analysis might help you to get a quick overview of the financial stability. However it is important to understand the FA Algorithm and the criterias before valuing it as a solution.

See FA Rationale
Framework:
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 754.89 1581.65 185.01
Graham Fair Price 69.58 11.68 6.89
PEG -91.39 0.04 -0.46
Price/Book -16.51 0.78 0.93
Price/Cash Flow -48.54 2.82 5.48
Prices/Earnings -71.00 7.85 27.08
Price/Sales -16.08 1.75 2.09
Price/FCF -48.54 2.82 5.48
Naive Interpretation member
01 - Valuation · Somewhat Positive
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 0.00 1.00 1.00
Operating Margin 370.17 0.05 0.01
ROA 182.95 < 0.005 < 0.005
ROE < 0.005 0.02 187.95
ROIC < 0.005 < 0.005 684.66
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.03 0.79 -96.35
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.59 3.66 525.29
EPS QOQ -0.59 2.00 236.84
FCF QOQ -0.64 0.62 -2.86
Revenue QOQ 2.03 < 0.005 -99.61
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 30.96 28.10 -9.25
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.79 0.79 0.67
Quick Ratio 0.65 0.67 3.07
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 15.63 15.62 -0.07
Cash 31.26 33.15 6.04
Capex -0.38 -0.17 56.49
Free Cash Flow 2.67 4.33 62.13
Revenue 6.99 6.95 -0.58
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 0.53 0.46 -13.16
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 137.54 1243.06 803.76
Naive Interpretation Member
06 - Financial Health · Bad
Rating